Mignon, Laurence et al "Design of the First-in-Human Study of IONIS-MAPTRx, a Tau-lowering Antisense Oligonucleotide, in Patients With Alzheimer Disease (S2.006)." Neurology 90.15 Supplement (2018): S2.006. Web. 21 May. 2022.